Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $312.9900 (0.08%) ($311.8400 - $317.4200) on Tue. Jun. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 65 | Latest Price | $312.9900(0.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities). VIXM(-25%) VXX(-11%) IFRA(-7%) TLT(-6%) TIP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | 0 () | Intraday Trend | -0% | | | |
|
5 Day Moving Average | $315.43(-0.77%) | 10 Day Moving Average | $311.62(0.44%) | 20 Day Moving Average | $308(1.62%) | To recent high | -24.5% | To recent low | 4.4% | Market Cap | $33.186b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |